Anthelmintic Drugs Market
The global anthelmintic drugs market, valued at $1 billion in 2022, is projected to grow at a compound annual growth rate (CAGR) of 3.8% to reach $1.5 billion by 2032. This growth is primarily driven by the increasing prevalence of helminth infections, particularly in regions with poor sanitation, limited access to clean water, and inadequate healthcare services.
Comments
Post a Comment